$DHC
Diversified Healthcare Trust Stock $dhc

$dhc Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000107541524000031 Filed on November 04, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2024 Q2
Revenue		$373.6M	$371.4M
YoY Change		4.8%	7.27%
Cost Of Revenue		$309.7M	$304.1M
YoY Change		3.77%	6.23%
Gross Profit		$63.94M	$67.33M
YoY Change		10.07%	12.23%
Gross Profit Margin		17.11%	18.13%
Selling, General & Admin		$13.93M	$6.262M
YoY Change		100.36%	-14.03%
% of Gross Profit		21.79%	9.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$68.96M	$68.36M
YoY Change		2.56%	-0.05%
% of Gross Profit		107.84%	101.53%
Operating Expenses		$82.89M	$74.62M
YoY Change		11.73%	-1.4%
Operating Profit		-$18.95M	-$7.292M
YoY Change		17.71%	-53.52%
Interest Expense		$59.44M	$58.70M
YoY Change		24.47%	-238.94%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$99.07M	-$85.38M
YoY Change		51.38%	13.42%
Income Tax		$148.0K	$170.0K
% Of Pretax Income
Net Earnings		-$98.69M	-$97.86M
YoY Change		50.03%	34.85%
Net Earnings / Revenue		-26.41%	-26.35%
Basic Earnings Per Share		-$0.41	-$0.41
Diluted Earnings Per Share		-$0.41	-$0.41
COMMON SHARES
Basic Shares Outstanding	241.3M shares	240.6M shares	240.4M shares
Diluted Shares Outstanding		239.7M shares	239.3M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$256.5M	$265.6M
YoY Change	-7.76%	-21.53%
Cash & Equivalents	$256.5M	$265.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$256.5M	$265.6M
YoY Change	-7.76%	-21.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.583B	$4.677B
YoY Change	-5.02%	-3.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$23.76M	$24.91M
YoY Change	-84.54%	-83.94%
Other Assets	$86.04M	$48.49M
YoY Change	236.08%	19.22%
Total Long-Term Assets	$5.029B	$5.068B
YoY Change	-4.26%	-3.41%
TOTAL ASSETS
Total Short-Term Assets	$256.5M	$265.6M
Total Long-Term Assets	$5.029B	$5.068B
Total Assets	$5.285B	$5.333B
YoY Change	-4.43%	-4.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$43.84M	$45.31M
YoY Change	-22.54%	-15.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$43.84M	$45.31M
YoY Change	-22.54%	-15.38%
LONG-TERM LIABILITIES
Long-Term Debt	$2.945B	$2.920B
YoY Change	5.76%	4.86%
Other Long-Term Liabilities	$247.7M	$218.9M
YoY Change	0.19%	-8.04%
Total Long-Term Liabilities	$3.193B	$3.139B
YoY Change	5.3%	3.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.84M	$45.31M
Total Long-Term Liabilities	$3.193B	$3.139B
Total Liabilities	$3.237B	$3.184B
YoY Change	4.79%	3.51%
SHAREHOLDERS EQUITY
Retained Earnings	$1.495B	$1.594B
YoY Change	-20.49%	-18.11%
Common Stock	$4.622B	$4.622B
YoY Change	0.04%	0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.048B	$2.149B
YoY Change
Total Liabilities & Shareholders Equity	$5.285B	$5.333B
YoY Change	-4.43%	-4.51%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$98.69M	-$97.86M
YoY Change	50.03%	34.85%
Depreciation, Depletion And Amortization	$68.96M	$68.36M
YoY Change	2.56%	-0.05%
Cash From Operating Activities	$21.13M	$44.29M
YoY Change	-250.62%	72.47%
INVESTING ACTIVITIES
Capital Expenditures	$47.25M	$41.00M
YoY Change	-21.86%	-13.95%
Acquisitions
YoY Change
Other Investing Activities	$22.06M	$4.145M
YoY Change		-70.41%
Cash From Investing Activities	-$25.19M	-$36.85M
YoY Change	-58.34%	9.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.628M	54.48M
YoY Change	32.95%	-409.01%
NET CHANGE
Cash From Operating Activities	21.13M	44.29M
Cash From Investing Activities	-25.19M	-36.85M
Cash From Financing Activities	-4.628M	54.48M
Net Change In Cash	-8.685M	61.92M
YoY Change	-88.86%	-342.02%
FREE CASH FLOW
Cash From Operating Activities	$21.13M	$44.29M
Capital Expenditures	$47.25M	$41.00M
Free Cash Flow	-$26.11M	$3.295M
YoY Change	-64.95%	-115.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001075415
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3445278
	dei	Entity Address City Or Town EntityAddressCityOrTown	Newton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02458-1634
	dei	City Area Code CityAreaCode	617
	dei	Local Phone Number LocalPhoneNumber	796 - 8350
	dei	Security12b Title Security12bTitle	Common Shares of Beneficial Interest
	dei	Trading Symbol TradingSymbol	DHC
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	241275373	shares
CY2024Q3	us-gaap	Land Land	623322000	usd
CY2023Q4	us-gaap	Land Land	652977000	usd
CY2024Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6049365000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6165490000	usd
CY2024Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	6672687000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	2020843000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4561995000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4797624000	usd
CY2024Q3	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	110513000	usd
CY2023Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	129916000	usd
CY2024Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	81163000	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	9447000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	256527000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	245939000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	4873000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	1022000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	79000	usd
	dei	Entity Registrant Name EntityRegistrantName	DIVERSIFIED HEALTHCARE TRUST
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	6818467000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	2110692000	usd
CY2024Q2	us-gaap	Dividends Common Stock DividendsCommonStock	2404000	usd
CY2024Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	940000	usd
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	42000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-272422000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-192766000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	189000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	505000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	379000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7192000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-276043000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	279105000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	us-gaap	Equity Method Investments EquityMethodInvestments	23758000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33948000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	218499000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	228240000	usd
CY2024Q3	dhc	Secured Debt And Finance Lease Obligations Net SecuredDebtAndFinanceLeaseObligationsNet	127836000	usd
CY2024Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	2617000	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	32000	usd
CY2024Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	22589000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	22847000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	3236792000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3109245000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	241281373	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	241281373	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240423898	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	240423898	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	2413000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2405000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4619990000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4618470000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1495469000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q3	dhc	Cumulative Common Stock Dividends CumulativeCommonStockDividends	4069476000	usd
CY2023Q4	dhc	Cumulative Common Stock Dividends CumulativeCommonStockDividends	4062262000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2048404000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2336891000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5285196000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5446136000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27868000	usd
CY2024Q3	us-gaap	Assets Assets	5285196000	usd
CY2023Q4	us-gaap	Assets Assets	5446136000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	373640000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	356524000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1115808000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1048773000	usd
CY2024Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	309697000	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	298432000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	921366000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	870740000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68959000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	67236000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	207449000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200430000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13933000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6954000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27763000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20111000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3676000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2243000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9812000	usd
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	23031000	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1156000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	41718000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	18380000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	415951000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	377454000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1200539000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1119473000	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	111000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-18976000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
CY2024Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	8126000	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2575000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	3243000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	7215000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	12572000	usd
CY2024Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	26188000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2293000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	76642000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6616000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	59443000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	47758000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	175721000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	142922000	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-209000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1075000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-99068000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-65445000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-98689000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-65779000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-282809000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-191008000	usd
CY2024Q3	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	34000	usd
	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	8000	usd
	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	0	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	34000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-98655000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-65779000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-282801000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-191008000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	239667000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	239667000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	239396000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	239396000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2336891000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-86259000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2404000	usd
CY2024Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	558000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2248703000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-97861000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	-22000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2149314000	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	270000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	1000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2583819000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-72571000	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssets
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssets
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilities
CY2024Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilities
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Two Newton Place, 255 Washington Street, Suite 300,
	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2023Q4	dhc	Secured Debt And Finance Lease Obligations Net SecuredDebtAndFinanceLeaseObligationsNet	13020000	usd
CY2024Q3	us-gaap	Other Liabilities OtherLiabilities	266295000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	269517000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1778278000	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	331000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	usd
CY2023Q3	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	0	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238892000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	238892000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238722000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	238722000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2024Q1	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	-4000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-98689000	usd
CY2024Q3	us-gaap	Oci Equity Method Investment After Tax OciEquityMethodInvestmentAfterTax	34000	usd
CY2024Q3	us-gaap	Dividends Common Stock DividendsCommonStock	2406000	usd
CY2024Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	932000	usd
CY2024Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	781000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2048404000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2638611000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52658000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2397000	usd
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	2397000	usd
CY2023Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	568000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	27000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	3000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2509389000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-65779000	usd
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	2398000	usd
CY2023Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	670000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	353000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	3000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2441526000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-282809000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-191008000	usd
	us-gaap	Depreciation Depreciation	207449000	usd
	us-gaap	Depreciation Depreciation	200430000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	76642000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6616000	usd
	us-gaap	Straight Line Rent StraightLineRent	1605000	usd
	us-gaap	Straight Line Rent StraightLineRent	-1333000	usd
	dhc	Amortization Of Acquired Real Estate Leases And Other Intangible Assets AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets	84000	usd
	dhc	Amortization Of Acquired Real Estate Leases And Other Intangible Assets AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets	-264000	usd
	dhc	Gain Loss On Early Extinguishment Of Debt GainLossOnEarlyExtinguishmentOfDebt	-209000	usd
	dhc	Gain Loss On Early Extinguishment Of Debt GainLossOnEarlyExtinguishmentOfDebt	-1075000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	41718000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	18380000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-18976000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	8126000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	405000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1328000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1231000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3870000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9882000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2137000	usd
	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	2199000	usd
	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	7995000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2828000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4315000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-258000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2628000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	22285000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-8864000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	94028000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17692000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	134966000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	168400000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	27845000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	3548000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	15459000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	1698000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
	dhc	Proceeds From Tender Offer ProceedsFromTenderOffer	0	usd
	dhc	Proceeds From Tender Offer ProceedsFromTenderOffer	14006000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-120882000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-150846000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	120000000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	250000000	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	60000000	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2388000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	16408000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	8203000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2057000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	902000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	386000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7214000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41293000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14439000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-409197000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246961000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	688302000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	261400000	usd
	us-gaap	Interest Paid Net InterestPaidNet	99337000	usd
	us-gaap	Interest Paid Net InterestPaidNet	133695000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	484000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	677000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	18603000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	29560000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	256527000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	278122000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	4873000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	983000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	261400000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	279105000	usd
CY2024Q3	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	368	property
CY2024Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	36	state
	dhc	Number Of States NumberOfStates	5	state
	dhc	Number Of Properties Acquired NumberOfPropertiesAcquired	0	property
CY2024Q3	us-gaap	Straight Line Rent StraightLineRent	658000	usd
CY2023Q3	us-gaap	Straight Line Rent StraightLineRent	676000	usd
	us-gaap	Straight Line Rent StraightLineRent	1605000	usd
	us-gaap	Straight Line Rent StraightLineRent	-1333000	usd
CY2024Q3	dhc	Straight Line Rent Excluding Properties Heldfor Sale StraightLineRentExcludingPropertiesHeldforSale	74088000	usd
CY2023Q4	dhc	Straight Line Rent Excluding Properties Heldfor Sale StraightLineRentExcludingPropertiesHeldforSale	75306000	usd
CY2024Q3	us-gaap	Variable Lease Payment VariableLeasePayment	11126000	usd
CY2023Q3	us-gaap	Variable Lease Payment VariableLeasePayment	12018000	usd
CY2024Q3	dhc	Reimbursement Revenue Lease ReimbursementRevenueLease	11083000	usd
CY2023Q3	dhc	Reimbursement Revenue Lease ReimbursementRevenueLease	11965000	usd
	us-gaap	Variable Lease Payment VariableLeasePayment	34111000	usd
	us-gaap	Variable Lease Payment VariableLeasePayment	36579000	usd
	dhc	Reimbursement Revenue Lease ReimbursementRevenueLease	33953000	usd
	dhc	Reimbursement Revenue Lease ReimbursementRevenueLease	36414000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20868000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	21254000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23366000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23748000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.01
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2404000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.01
CY2024Q2	us-gaap	Dividends Common Stock DividendsCommonStock	2404000	usd
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.01
CY2024Q3	us-gaap	Dividends Common Stock DividendsCommonStock	2406000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.03
	us-gaap	Dividends Common Stock DividendsCommonStock	7214000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	373640000	usd
CY2024Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	309697000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68959000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13933000	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	331000	usd
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	23031000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	415951000	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	111000	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2575000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	59443000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-99068000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	527000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-98689000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1115808000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	921366000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	207449000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27763000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2243000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	41718000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1200539000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-18976000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	7215000	usd
	us-gaap	Interest Expense InterestExpense	175721000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-209000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-272422000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	505000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9882000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-282809000	usd
CY2024Q3	us-gaap	Assets Assets	5285196000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	356524000	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	298432000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	67236000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6954000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3676000	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1156000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	377454000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	3243000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	47758000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-65445000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	189000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-145000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-65779000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1048773000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	870740000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200430000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20111000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9812000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	18380000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1119473000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	8126000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	12572000	usd
	us-gaap	Interest Expense InterestExpense	142922000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1075000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-192766000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	379000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2137000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-191008000	usd
CY2023Q4	us-gaap	Assets Assets	5446136000	usd
CY2024Q3	dei	Entity Number Of Employees EntityNumberOfEmployees	0	employee
CY2024Q3	dhc	Property Management And Construction Supervision Fees PropertyManagementAndConstructionSupervisionFees	1787000	usd
CY2023Q3	dhc	Property Management And Construction Supervision Fees PropertyManagementAndConstructionSupervisionFees	2209000	usd
	dhc	Property Management And Construction Supervision Fees PropertyManagementAndConstructionSupervisionFees	5411000	usd
	dhc	Property Management And Construction Supervision Fees PropertyManagementAndConstructionSupervisionFees	6403000	usd
CY2024Q3	dhc	Property Management And Construction Supervision Fees Paid PropertyManagementAndConstructionSupervisionFeesPaid	4007000	usd
CY2023Q3	dhc	Property Management And Construction Supervision Fees Paid PropertyManagementAndConstructionSupervisionFeesPaid	3671000	usd
	dhc	Property Management And Construction Supervision Fees Paid PropertyManagementAndConstructionSupervisionFeesPaid	11448000	usd
	dhc	Property Management And Construction Supervision Fees Paid PropertyManagementAndConstructionSupervisionFeesPaid	10765000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	189000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	505000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	379000	usd

Files In Submission

Name	View Source	Status
0001075415-24-000031-index-headers.html	Edgar Link	pending
0001075415-24-000031-index.html	Edgar Link	pending
0001075415-24-000031.txt	Edgar Link	pending
0001075415-24-000031-xbrl.zip	Edgar Link	pending
dhc-20240930.htm	Edgar Link	pending
dhc-20240930.xsd	Edgar Link	pending
dhc_093024xexhibitx311.htm	Edgar Link	pending
dhc_093024xexhibitx312.htm	Edgar Link	pending
dhc-20240930_cal.xml	Edgar Link	unprocessable
dhc-20240930_def.xml	Edgar Link	unprocessable
dhc-20240930_pre.xml	Edgar Link	unprocessable
dhc-20240930_lab.xml	Edgar Link	unprocessable
dhc-20240930_htm.xml	Edgar Link	completed
dhc_093024xexhibitx321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DHC
Diversified Healthcare Trust Stock $dhc

2024 Q4 Form 10-Q Financial Statement

#000107541524000031 Filed on November 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHC Diversified Healthcare Trust Stock $dhc

2024 Q4 Form 10-Q Financial Statement

#000107541524000031 Filed on November 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHC
Diversified Healthcare Trust Stock $dhc